Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.38 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12154154 | 0.89 | THRB (0.42) | THRBRARARARBFFAR4FFAR1 | |
| SCHEMBL14984618 | 0.88 | THRB (0.40) | THRBAPPCYP2C19FFAR4FFAR1 | |
| SCHEMBL14088550 | 0.87 | THRB (0.48) | THRBRARARARBAPPCYP2C19 | |
| SCHEMBL815645 | 0.86 | THRB (0.47) | THRBRARARARBFFAR4FFAR1 | |
| SCHEMBL12154282 | 0.85 | TP53 (0.31) | THRBRARARARBFYNFEN1 | |
| SCHEMBL11917942 | 0.84 | THRB (0.53) | THRBRARBCYP3A4 | |
| SCHEMBL14010385 | 0.83 | THRB (0.46) | THRB | |
| SCHEMBL9607896 | 0.83 | THRB (0.43) | THRBAPPCYP2C19CYP3A4CYP2C9 | |
| SCHEMBL17754264 | 0.82 | FFAR1 (0.34) | THRBFFAR4FFAR1AKR1C3 | |
| SCHEMBL19917676 | 0.82 | MEN1 (0.40) | THRBRARARARBCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170073581-A1 | MIXTURE THAT INCLUDES COMPOUND CONTAINING MESOGENIC GROUP | DIC CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20170066967-A1 | POLYMERIZABLE COMPOSITION COMPRISING COMPOUND HAVING MESOGENIC GROUP, AND POLYMER THEREOF | DIC CORPORATION (JP) | 2017-03-09 | — | — | US | disclosed |
| US-7919009-B2 | Polymerizable compounds and polymerizable compositions | ADEKA CORPORATION (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7910021-B2 | Polymerizable optical active compound and polymerizable composition containing the same | ADEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20100032621-A1 | POLYMERIZABLE COMPOUNDS AND POLYMERIZABLE COMPOSITIONS | ADEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | C1S, PYM1, MCCC2 | THRB 3247/4885RARA 2388/4885RARB 3096/4885 |
| US-20100032621-A1 | POLYMERIZABLE COMPOUNDS AND POLYMERIZABLE COMPOSITIONS | CHRM1, CHRM2, CCNE1 | THRB 4880/4885RARA 4019/4885RARB 4300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.